Evidence map›Paper›PMID 42263077›Full record

ArticleReproduction & fertility2026

Higher BMI is associated with vaginal microbiome alterations in women with PCOS.

Marta Spochacz-Santoro, Anna Szeliga, Magdalena Durda-Masny, Katarzyna Morańska, Monika Englert-Golon, Wawrzyniec Sadowski, Maria Bocheńska, Swapnil Doijad, Bas E Dutilh, Rose Brouns and 4 more

Abstract read
In one paragraph

Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marta Spochacz-SantoroInstitute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.ORCID https://orcid.org/0000-0003-3944-519X
Anna SzeligaDepartment of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland.
Magdalena Durda-MasnyInstitute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.
Katarzyna MorańskaInstitute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.
Monika Englert-GolonDepartment of Gynecology, Division of Gynecological Oncology, Gynecological Obstetric Clinical Hospital, Poznan University of Medical Sciences, Poznan, Poland.
Wawrzyniec SadowskiInstitute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.
Maria BocheńskaInstitute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.
Swapnil DoijadInstitute of Biodiversity, Ecology, and Evolution, Faculty of Biological Sciences, Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany.
Bas E DutilhInstitute of Biodiversity, Ecology, and Evolution, Faculty of Biological Sciences, Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany.
Rose BrounsInstitute of Biodiversity, Ecology, and Evolution, Faculty of Biological Sciences, Cluster of Excellence Balance of the Microverse, Friedrich Schiller University Jena, Jena, Germany.
Marlena GrabowskaDepartment of Gynecology, Division of Gynecological Oncology, Gynecological Obstetric Clinical Hospital, Poznan University of Medical Sciences, Poznan, Poland.
Stefan SajdakDivision of Gynecology, Gynecological Obstetric Clinical Hospital, Poznan University of Medical Sciences, Poznan, Poland.
Błażej MęczekalskiDepartment of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland.
Anita SzwedInstitute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract: Polycystic ovary syndrome (PCOS) is commonly associated with obesity and metabolic disturbances. Although gut and vaginal microbiome changes have been linked to PCOS, the independent role of body mass index in these alterations remains unclear. This study aimed to compare gut and vaginal microbiomes in women with PCOS and healthy controls, emphasizing the impact of body mass index. Seventy-five women were enrolled, including 55 with PCOS and 20 healthy controls. Participants were stratified into normal-weight (<25) and overweight (≥25) groups. Vaginal and anorectal swabs were analyzed using full-length 16S rRNA nanopore sequencing. Microbial diversity and composition were assessed with alpha diversity indices, principal component analysis, analysis of composition of microbes, PERMANOVA, and vaginal community state type classification. Without body mass index stratification, women with PCOS showed differences in several vaginal taxa compared with healthy controls. Within the PCOS cohort, overweight women exhibited higher vaginal alpha diversity, reduced Lactobacillus dominance, and enrichment of anaerobic taxa compared with normal-weight women with PCOS. Differences in vaginal microbial composition were also observed between healthy and PCOS women with normal body mass index. In contrast, gut microbiome alterations were limited and less consistent across analytical approaches. Vaginal community state type analysis revealed predominance of class IV communities in both healthy women and women with PCOS. These findings suggest that higher body mass index is associated with vaginal microbiome alterations in women with PCOS, although PCOS-related factors independent of body weight may also contribute to the observed microbial differences. Lay summary: Polycystic ovary syndrome is a common condition that affects hormones, fertility, and metabolism in women. Many women with this condition are also overweight, but it is not fully understood how body weight influences the bacteria living in the body. In this study, we compared bacteria present in vaginal and anorectal samples from women with and without polycystic ovary syndrome, while also considering body weight. We found that women with higher body weight had more noticeable changes in vaginal bacterial composition, including lower amounts of protective Lactobacillus bacteria and higher diversity of anaerobic bacteria. At the same time, some bacterial differences were also observed in women with polycystic ovary syndrome who had normal body weight. Changes in gut bacteria were smaller and less consistent. These findings suggest that both body weight and polycystic ovary syndrome may influence vaginal bacterial composition and should be considered in future studies of women's reproductive health.

Indexed as

Body Mass IndexMicrobiotaPolycystic Ovary SyndromeVaginaAdultCase-Control StudiesFemaleGastrointestinal MicrobiomeHumansOverweightYoung AdultBMIbody mass indexgut microbiotaPCOSpolycystic ovary syndromevaginal microbiota

Identifiers

PMID42263077
PMCPMC13292985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.